TraderMade Bows iMaverick Web Charts, Commentary

iMaverick─which has existed in various proof-of-concept forms for some time, but was pulled together from different datasets at the end of last year─is aimed at former institutional traders who still trade FX, as well as corporate treasurers and FX sales professionals, who can subscribe to the tool for between £100 and £300 per month on a standalone basis, depending on the data they access, or can access it free of charge if they are an existing subscriber to other TraderMade products.

The

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Nasdaq reshuffles tech divisions post-Adenza

Adenza is now fully integrated into the exchange operator’s ecosystem, bringing opportunities for new business and a fresh perspective on how fintech fits into its strategy.

Deutsche Börse democratizes data with Marketplace offering

Deutsche Börse Group is set to unveil its Marketplace, a one-stop data shop designed to simplify and streamline data acquisition and consumption for its clients, while also surfacing data from across the firm to its own users. Jan Stiebing and Sven…

The IMD Wrap: The growing data catalogue space

With their potential to manage costs and surface strategic datasets, it’s no wonder Max gets excited about data catalogs. This week, he takes a look at a new startup entering the space.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here